[{"id":"307f73d9-02fe-4164-bff8-b7e3cc8feaa3","acronym":"","url":"https://clinicaltrials.gov/study/NCT04429438","created_at":"2021-01-18T21:20:00.358Z","updated_at":"2024-07-02T16:36:44.235Z","phase":"Phase 1/2","brief_title":"Multi-CAR-T Cells Targeting B Cell Lymphomas","source_id_and_acronym":"NCT04429438","lead_sponsor":"Shenzhen Geno-Immune Medical Institute","biomarkers":" CD19 • CD79B • CD22 • CD70 • ANPEP","pipe":" | ","alterations":" CD19 expression","tags":["CD19 • CD79B • CD22 • CD70 • ANPEP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e multi-CAR-T cell therapy"],"overall_status":"Recruiting","enrollment":" Enrollment 11","initiation":"Initiation: 06/01/2020","start_date":" 06/01/2020","primary_txt":" Primary completion: 07/31/2023","primary_completion_date":" 07/31/2023","study_txt":" Completion: 12/31/2023","study_completion_date":" 12/31/2023","last_update_posted":"2020-06-12"}]